Ex parte MASON - Page 9




          Appeal No. 96-1790                                                          
          Application No. 08/285,375                                                  


          has not included any explanation that “tensile elongation” is               
          an accepted test for chemical resistance, nor any explanation               
          of what constitutes “critical strain” and how is it                         
          determined.  The comparative examples on page 13 of the                     
          specification also contain polytetrafluoroethylene (PTFE)                   
          which is not required in the molding composition of appealed                
          claim 1.  Appellant has not shown that the differences in                   
          results, especially in Table 3, are in fact unexpected and of               
          statistical and practical significance.  In re Mayne, 104 F.3d              
          1339, 1344, 41 USPQ2d 1451, 1456 (Fed. Cir. 1997)(“Even [sic,               
          if] it were obvious to a practitioner of the art [that the                  
          results were unexpected], applicants have the burden to                     
          provide the PTO with evidence showing that such is the                      
          case.”).                                                                    
               “After evidence or argument is submitted by the applicant              
          in response [to a case of prima facie obviousness],                         
          patentability is determined on the totality of the record, by               
          a preponderance of evidence with due consideration to                       
          persuasiveness of argument. [Citations omitted].”  In re                    
          Oetiker, 977 F.2d 1443, 1445, 24 USPQ2d 1443, 1444 (Fed. Cir.               


                                          9                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007